Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.13 CAD
Change Today -0.005 / -3.85%
Volume 95.8K
SL On Other Exchanges
Symbol
Exchange
Venture
OTC US
Frankfurt
Venture
Frankfurt
As of 3:47 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

supreme pharmaceuticals inc (SL) Snapshot

Open
C$0.13
Previous Close
C$0.13
Day High
C$0.13
Day Low
C$0.12
52 Week High
10/22/14 - C$0.53
52 Week Low
08/19/15 - C$0.11
Market Cap
3.2M
Average Volume 10 Days
101.9K
EPS TTM
C$-0.12
Shares Outstanding
25.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SUPREME PHARMACEUTICALS INC (SL)

Related News

No related news articles were found.

supreme pharmaceuticals inc (SL) Related Businessweek News

No Related Businessweek News Found

supreme pharmaceuticals inc (SL) Details

Supreme Pharmaceuticals Inc., a development stage company, focuses on the production and sale of medical marijuana in Canada. The company was formerly known as Supreme Resources Ltd. and changed its name to Supreme Pharmaceuticals Inc. in February 2014. Supreme Pharmaceuticals Inc. was incorporated in 1979 and is headquartered in Vancouver, Canada.

Founded in 1979

supreme pharmaceuticals inc (SL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

supreme pharmaceuticals inc (SL) Key Developments

Supreme Pharmaceuticals Inc. Announces Executive Changes

Supreme Pharmaceuticals Inc. announced in relation to the previously announced management transition to Ontario, Tatiana Kovaleva will be resigning as the Company's Chief Financial Officer. Cailin Ghelsen, the Director of Finance for the Company's wholly owned subsidiary 8528934 Canada Ltd. ('AMMCan'), will be appointed as the interim Chief Financial Officer. Peter Herburger, the CEO of AMMCan, will be appointed as Supreme's Director of Operations.

Supreme Pharmaceuticals Inc. Completes Operational Transition to Ontario; Announces Resignation of Brayden Sutton as Executive Vice-President

Supreme Pharmaceuticals Inc. announced it has completed its operational transition from British Columbia to Ontario in order to focus resources on the Kincardine facility. The transition allows the company to reduce operating overhead and focus efforts on obtaining required regulatory approvals at the Kincardine facility. Further to the transition, Brayden Sutton will be resigning as Executive Vice-President, effective immediately, but will continue on with company as a consultant for the near term to assist in completing the company's operational transition.

Supreme Pharmaceuticals Inc. Announces Management Changes

Supreme Pharmaceuticals Inc. announced that at its annual meeting John Fowler was elected to the board of directors and appointed as the President of the Company. The Company has also added Dr. Youbin Zheng to its advisory board. Mr. John Fowler, previously Director of Operations, was elected to the board of directors, and will be assuming the position of President of Supreme. Mr. Fowler began working in the medical marijuana sector over ten years ago. He pursued a career in law to assist medical marijuana patients with legal issues ancilliary to medical marijuana use. Most recently, Mr. Fowler practiced law at a prominent Toronto law firm. Mr. Fowler is committed to providing Canadians access to high-quality, low-cost medical marijuana and working with the medical community to improve physician education and support for medical marijuana. Dr. Youbin Zheng, PhD, MPhil, MAg, Bag, has been appointed as the newest member of the Company’s advisory board. Mr. Zheng is currently an Associate Professor and Environmental Horticulture Chair, at the University of Guelph. He has many years of experience in horticulture research, especially in vegetable and ornamental plant production in controlled environments in Canada, England, Japan and China. Recent research projects include greenroofs, urban agriculture, organic vegetable production in greenhouses, CO2 enrichment and its effects on photosynthesis, respiration, transpiration, nutrient uptake and crop production, irrigation and water treatment for sustainable horticulture, and the development of sustainable plant production systems. Mr. Zheng is a highly distinguished expert in the field of horticulture and will be a key advisor to the Company and its grow operations moving forward.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SL:CN C$0.13 CAD -0.005

SL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SL.
View Industry Companies
 

Industry Analysis

SL

Industry Average

Valuation SL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUPREME PHARMACEUTICALS INC, please visit www.supremeresourcesltd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.